Skip to main content

Eli Greenspan

ML Strategies - Manager of Government Relations

[email protected]

+1.202.434.7420

Share:

Prior to joining ML Strategies, Eli was a legislative correspondent for US Senator Martin Heinrich (D-NM), where his experience included health care, education, child welfare, social security, food assistance, and poverty issues specifically as they relate to the Affordable Care Act, Medicare, and Social Security. Previously, Eli served as a legislative intern with Senator Heinrich. He also served as a legislative intern with Senator Dick Durbin (D-IL), where he worked on issues related to education, health, and commerce. Eli has also served as an intern at a political fundraising and strategy firm in Chicago.

Outside of politics, Eli was the founder of MLB Daily Dish, a blog devoted to Major League Baseball. He also was the lead sports writer for ChicagoNow’s Down on the Farm, where he covered the Cubs and White Sox minor league teams

Education

  • University of Maryland (BA)

Recognition & Awards

  • Yitzhak Rabin Memorial Fellow (2011 – 2012)

Recent Insights

News & Press

Viewpoints

Viewpoint General
This week, the House Energy & Commerce Committee is voting on seven more drug pricing bills. The Senate is going to be unveiling its cost-containment package in the coming weeks (if not days) and should include most, if not all, of the House-passed drug pricing bills. This action will set the stage for the summer work period, which is expected to focus heavily on drug pricing and other cost-containment measures, such as surprise medical bills. At CMS, the agency published a final rule last week that touched on several noteworthy drug pricing issues. We cover this and more in this week's preview, which you can find by clicking here. 
Viewpoint General

ML Strategies Health Care Preview: Congress's Summer Plans Filling Up Fast

May 13, 2019 | Blog | By Eli Greenspan, Alexander Hecht

Congress is circling an issue that is not black and white in terms of the stakeholders it could impact and how interests will align. The leaders of the Senate Health, Education, Labor, and Pensions Committee and the Senate Finance Committee are poised to release a cost-containment package in the coming weeks which will touch on surprise billing issues, drug pricing, and other access and transparency issues. While there is intense bipartisan interest in addressing some of these issues, it is unclear how exactly this package will reach the President's desk given the current political climate.
Viewpoint General

ML Strategies Health Care Preview: House Poised to Pass First Drug Pricing Bills

May 8, 2019 | Blog | By Eli Greenspan, Alexander Hecht

This week, the House is poised to take action on drug pricing by passing two pieces of legislation. As the House moves bills through final passage, focus will shift to the Senate which will in the coming weeks unveil a legislative package around lowering costs for consumers. The scope of this package is still unclear, but it should include a number of proposals that could pass on a bipartisan basis. We cover this and more in this week's preview, which you can find by clicking here. 
Viewpoint General

MLS Weekly Preview: Medicare For All Gets a Hearing

April 29, 2019 | Blog | By Eli Greenspan, Alexander Hecht

Following the two week recess, Congress is back in session and will have several high profile hearings this week. For starters, the Energy & Commerce Health subcommittee will continue reviewing prescription drug costs, this time focusing in on Medicare. In the Rules Committee, which does not typically host high profile hearings, they will hold the first committee hearing on H.R. 1384, one of the "Medicare for All" proposals.


The House is poised to pass several noteworthy drug pricing bills this work period, as well as legislation to strengthen the Affordable Care Act. Once the House votes on these bills, the question will then become what is the Senate able to pass and what is their appetite for taking it on this summer. We cover this and more in this week's preview.
Viewpoint General

MLS Weekly Preview: Congress Keeping its Focus on Drug Costs

April 8, 2019 | Blog | By Eli Greenspan, Alexander Hecht

This week, Congress will continue to look at lowering health costs. The House has been focused on both drug costs and overall health care costs, advancing packages to strengthen the individual market in addition to a series of bipartisan drug pricing bills. We cover this and more in this week's preview.
Viewpoint General

ML Strategies Health Care Preview - Week of March 25, 2019

March 26, 2019 | Blog | By Eli Greenspan

This week, House Democrats are pressing forward with a health care package designed to lower drug costs and strengthen the Affordable Care Act (ACA). This package will provide a platform for Democrats to tout legislation that stabilizes the ACA or counteracts actions taken by the Administration. While this legislative package is sure to get a lot of attention following the Department of Justice announcement regarding Texas v. Azar, it's unclear how much support it will garner in the Senate.
Viewpoint General

ML Strategies Health Care Preview - Week of March 4, 2019

March 4, 2019 | Blog | By Eli Greenspan

As Congress continues its oversight of prescription drug prices, the Senate Finance Committee will also examine abuse and neglect at nursing homes. Meanwhile, the House of Representatives is looking at ways to lower health care costs as it keeps it eye on lowering drug costs as well. The focus and intensity around drug pricing is not expected to diminish anytime soon. For our complete health care preview...
Viewpoint General

What Does the Future Hold for Drug Pricing?

February 28, 2019 | Blog | By Eli Greenspan

On Tuesday, executives from seven of the largest pharmaceutical companies testified before the Senate Finance Committee on rising prescription drug prices. While the hearing was expected to be packed with fireworks as Senators of both parties grilled the nation's top pharmaceutical executives, it was largely uneventful.
Viewpoint General

ML Strategies Health Care Preview - Week of February 25th

February 26, 2019 | Blog | By Eli Greenspan

This week, Congress will dive into rising prescription drug costs with a hearing in the Senate Finance Committee. The hearing will feature seven top drug manufacturer executives and will focus on rising drug prices and transparency, among other topics. The Finance Committee is also looking into insulin price increases, joining the House Oversight Committee in investigating a number of prescription drug price increases. We cover this and more in this week's preview, which you can find by...
Viewpoint General

ML Strategies Health Care Preview - Week of February 11, 2019

February 11, 2019 | Blog | By Eli Greenspan

Congress and the Administration are staring down the prospects of another government shutdown with talks breaking down over the weekend on a border funding deal. Democrats in the House continue to aggressively pursue drug pricing legislation, and are also touting reforms to the ACA to counteract actions taken by the Administration. Once we're beyond the shutdown, assuming a long-term deal can be struck, legislative direction on key issues should become clear. We cover this and more in this week's preview, which you can find...

News & Press

ML Strategies Executive VP & Director of Operations Alex Hecht and Manager of Government Relations Eli Greenspan authored this HFMA Advisor article discussing the impact that states transitioning their Medicaid populations into managed care has had on individuals with traumatic brain injuries.
Alex Hecht, ML Strategies Executive Vice President and Director of Operations; Eli Greenspan, ML Strategies Manager of Government of Relations; and Rodney Whitlock, ML Strategies Vice President, authored a Physician Solutions Magazine article discussing growing interest in telemedicine.